Aurobindo’s Divestiture of Natrol

Code : MAA0227

Year :
2021

Industry : -

Region : -

Teaching Note:Available

Structured Assignment :Not Available

Buy This Case Study        

Introduction: On October 26, 2020, the management of India-based Aurobindo Pharma Limited (Aurobindo) announced the sale of its US subsidiary, Natrol Inc (Natrol), for US$ 550 million (approximately Rs. 40,480 million). In its announcement Aurobindo said Natrol, which manufactured vitamins, minerals, and supplements, would be acquired by US-based alternative investment manager New Mountain Capital, and would be combined with its subsidiary Jarrow Formulas, a US-based formulator and supplier of nutritional supplements. “We are pleased to sell the Natrol business to an outstanding private equity player that can focus additional resources to grow Natrol, its products and brands further,” said N Govindarajan, Managing Director, Aurobindo Pharma ..

For Case Books Click Here >>

For Case eBooks Click Here >>

Case Excerpts >>






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-500 082, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020 - 25 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap